跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Hospira Paclitaxel concentrate for solution for infusion, 300 mg/50 mL Oncotain
Approved
STANDARD
Hospira Paclitaxel concentrate for solution for infusion, 300 mg/50 mL Oncotain
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
78501deccedf3c92
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
78501deccedf3c92
Product Name
Hospira Paclitaxel concentrate for solution for infusion, 300 mg/50 mL Oncotain
Artg Id
155925
Artg Name
Hospira Paclitaxel concentrate for solution for infusion, 300 mg/50 mL Oncotain
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2008-10-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
78501deccedf3c92
Type
Standard
Back to TGA Approvals
Hospira Paclitaxel concentrate for solution for infusion, 300 mg/50 mL Oncotain - TGA Drug Approval Details
